BHLHE40 and ChREBP associate with hepatic enhancer clusters containing PPARα, RXRα, and HNF4 nuclear receptors
Endocrinology · 2026
DOI: 10.1210/endocr/bqag095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2026. Verfasst von Krista Kokki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biological and Environmental Sciences, University of Helsinki, 00790 Helsinki, Finland. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 4, PPAR alpha, Retinoid X Receptor alpha, Basic Helix-Loop-Helix Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Council of Finland, Sigrid Juselius Foundation, Novo Nordisk Foundation.
Abstract (Originalsprache)
BHLHE40/DEC1 is a basic helix-loop-helix transcription factor (TF) that regulates circadian rhythm and T-cell responses. In hepatocytes, its function and interplay with other TFs are poorly understood. Employing a genome-wide approach, we show that its genomic binding strongly overlapped with that of carbohydrate response-element binding protein, a sugar-sensing TF and known inducer of BHLHE40 expression. Transcriptomic analysis of primary mouse hepatocytes revealed reduced expression of genes involved in genomic stability on Bhlhe40 knockdown by siRNA. Bhlhe40 depletion potentiated fructose responsiveness of genes involved in cell-cycle regulation. Strikingly, genomic binding of BHLHE40 extensively overlapped with enhancers occupied by PPARα, RXRα, and HNF4 nuclear receptors and BHLHE40 fine-tuned the expression of PPARα target genes. Using HEK293 cells, we further observed that BHLHE40 physically interacted with RXRα and PPARα cofactors. Collectively, our data suggest that through cooperation with carbohydrate response-element binding protein and nuclear receptors, BHLHE40 is a central regulator of hepatic gene expression with potential to integrate inputs from nutrient signals contributing to the metabolic flexibility of the liver.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Biological and Environmental Sciences, University of Helsinki, 00790 Helsinki, Finland.
- Institute of Biotechnology, Helsinki Institute of Life Science, University of Helsinki, 00790 Helsinki, Finland.
- Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Charité-Universitätsmedizin Berlin, corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Institute of Pharmacology, 10115 Ber…
ORCID-Profile: Marius Robciuc, Markku Varjosalo, Michael Schupp, Ville Hietakangas
Förderung
- Research Council of Finland
- Sigrid Juselius Foundation
- Novo Nordisk Foundation
- German Research Foundation
Zitieren
APA
Kokki, K., Wowro, S. J., Robciuc, M., Hallasaari, A., Porri, L., Kinnunen, M., Stegmann, C. A., Petricek, K. M., Varjosalo, M., Schupp, M., & Hietakangas, V. (2026). BHLHE40 and ChREBP associate with hepatic enhancer clusters containing PPARα, RXRα, and HNF4 nuclear receptors. Endocrinology. https://doi.org/10.1210/endocr/bqag095
Vancouver
Kokki K, Wowro SJ, Robciuc M, Hallasaari A, Porri L, Kinnunen M, et al. BHLHE40 and ChREBP associate with hepatic enhancer clusters containing PPARα, RXRα, and HNF4 nuclear receptors. Endocrinology. 2026. doi:10.1210/endocr/bqag095
BibTeX
@article{Kokki2026,
author = {Kokki, Krista and Wowro, Sylvia J and Robciuc, Marius and Hallasaari, Atte and Porri, Linda and Kinnunen, Matias and Stegmann, Catrin A and Petricek, Konstantin M and Varjosalo, Markku and Schupp, Michael and Hietakangas, Ville},
title = {BHLHE40 and ChREBP associate with hepatic enhancer clusters containing PPARα, RXRα, and HNF4 nuclear receptors},
journal = {Endocrinology},
year = {2026},
doi = {10.1210/endocr/bqag095}
}
EUVIMED